This site is intended for health professionals only

News

Weekly tirzepatide produces significant weight loss in obese patients
Weekly tirzepatide produces significant weight loss in obese patients
CVD risk after prolonged sitting more prominent in lower income countries
CVD risk after prolonged sitting more prominent in lower income countries
Combining pomegranate juice with aerobic training improves risk factors in type 2 diabetes
Combining pomegranate juice with aerobic training improves risk factors in type 2 diabetes
Meta-analysis shows all-cause mortality risk reduced in CHD by keeping physically active
Meta-analysis shows all-cause mortality risk reduced in CHD by keeping physically active
Analysis shows heart failure exercise-based cardiac rehabilitation programs equally beneficial
Analysis shows heart failure exercise-based cardiac rehabilitation programs equally beneficial
Added clinical benefits of molnupiravir in COVID-19 possible
Added clinical benefits of molnupiravir in COVID-19 possible
Meta-analysis suggests omega-3 supplements not effective for depression in cardiometabolic disease
Meta-analysis suggests omega-3 supplements not effective for depression in cardiometabolic disease
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
Study finds similar mortality benefit for unsweetened and coffee sweetened with sugar
Study finds similar mortality benefit for unsweetened and coffee sweetened with sugar
Meta-analysis finds vasopressor use in critically ill COVID-19 patients linked to higher mortality
Meta-analysis finds vasopressor use in critically ill COVID-19 patients linked to higher mortality
Do SGLT-2 inhibitors and metformin as first-line treatments in type 2 diabetes produce similar cardiovascular outcomes?
Do SGLT-2 inhibitors and metformin as first-line treatments in type 2 diabetes produce similar cardiovascular outcomes?
Metformin or lifestyle interventions unable to reduce major adverse CV event risk in pre-diabetics
Metformin or lifestyle interventions unable to reduce major adverse CV event risk in pre-diabetics
1 2 3 4 … 698


Most read

1
Feedback: Automation systems in your hospital
2
Merck agrees huge Vioxx settlement
3
Helapet introduce new, improved 20mm Vented Vial Adapter
4
Janssen-Cilag’s Stelara approved by NICE
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe